Staphylokinase promotes the establishment of staphylococcus aureus skin infections while decreasing disease severity

Journal of Infectious Diseases

Volumn 208, Issue 6, 2013, Pages 990-999

  Kwiecinski, Jakub ^a   Jacobsson, Gunnar ^b   Karlsson, Maria ^c   Zhu, Xuefeng ^a   Wang, Wanzhong ^d   Bremell, Tomas ^a   Josefsson, Elisabet ^a   Jin, Tao ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SKARABORG HOSPITAL   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

mouse model; pathogen host relation; plasminogen; skin infection; staphylococcus; staphylokinase

Indexed keywords

PLASMINOGEN; STAPHYLOKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN PENETRATION; STAPHYLOCOCCAL SKIN INFECTION;

MOUSE MODEL; PATHOGEN-HOST RELATION; PLASMINOGEN; SKIN INFECTION; STAPHYLOCOCCUS; STAPHYLOKINASE;

ABSCESS; ANIMALS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MALE; METALLOENDOPEPTIDASES; MICE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; SKIN; SKIN DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84883248189     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit288     Document Type: Conference Paper

References (31)

1. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and theWestern Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S114-32.
2. Nickerson EK, West TE, Day NP, Peacock SJ. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis 2009; 9:130-5.
3. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011; 11:505-18.
4. Wilson J, Guy R, Elgohari S, et al. Trends in sources of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. J Hosp Infect 2011; 79:211-7.
5. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39:6-13.
6. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: staphylokinase. Int J Biochem Cell Biol 2006; 38:504-9.
7. Okada K, Ueshima S, Tanaka M, Fukao H, Matsuo O. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice. Blood Coagul Fibrinolysis 2000; 11:645-55.
8. Lahteenmaki K, Edelman S, Korhonen TK. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 2005; 13:79-85.
9. Lahteenmaki K, Kuusela P, Korhonen TK. Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 2001; 25:531-52.
10. Molkanen T, Tyynela J, Helin J, Kalkkinen N, Kuusela P. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett 2002; 517:72-8.
11. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258:1004-7.
12. Sun H, Ringdahl U, Homeister JW, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305:1283-6.
13. Kwiecinski J, Josefsson E, Mitchell J, et al. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis 2010; 202:1041-9.
14. Sjolund M, Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis 2008; 40:894-8.
15. Molne L, Verdrengh M, Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 2000; 68:6162-7.
16. Lijnen HR, Stassen JM, Collen D. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis. Thromb Haemost 1995; 73:845-9.
17. Menzies BE, Kenoyer A. Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 2005; 73:5241-4.
18. Braff MH, Jones AL, Skerrett SJ, Rubens CE. Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. J Infect Dis 2007; 195:1365-72.
19. del Giudice P, Blanc V, de Rougemont A, et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 2009; 219:299-302.
20. Burge SM, Marshall JM, Cederholm-Williams SA. Plasminogen binding sites in normal human skin. Br J Dermatol 1992; 126: 35-41.
21. Bergmann S, Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007; 98:512-20.
22. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 2010; 6:e1001036.
23. Guggenberger C,Wolz C, Morrissey JA, Heesemann J. Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog 2012; 8:e1002434.
24. Vanassche T, Verhaegen J, Peetermans WE, et al. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost 2011; 9:2436-46.
25. Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012; 92:509-19.
26. Guo Y, Li J, Hagstrom E, Ny T. Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. Arthritis Rheum 2008; 58:764-72.
27. Li WY, Chong SS, Huang EY, Tuan TL. Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen 2003; 11:239-47.
28. Toriseva M, Kahari VM. Proteinases in cutaneous wound healing. Cell Mol Life Sci 2009; 66:203-24.
29. Guo Y, Li J, Hagstrom E, Ny T. Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. PLoS One 2011; 6: e24774.
30. Kak M, Anakkala N, Wang W, et al. Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis 2010; 42:351-8.
31. Jin T, Bokarewa M, McIntyre L, et al. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003; 52:919-23.